The direct binding of Dclk1 to KRAS protein is the key factor in the activation of MAPK in pancreatic cancer cells (121), indicating the functional interaction of G9a, DCLK1, and MAPK pathways in KRAS-driven PDAC (122). Here, KRAS is linked to pancreatic neoplasm.